Clinical Trial Update: Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of povetacicept in adults with Immunoglobulin A nephropathy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• Povetacicept (povetacicept)

Snippet

Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex | Conditions: Immunoglobulin A Nephropathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING